Nuclear and Optical Bimodal Imaging Probes Using Sequential Assembly: A Perspective-Reference-Cited by-同舟云学术

Nuclear and Optical Bimodal Imaging Probes Using Sequential Assembly: A Perspective

Published:2018-10 Issue:8 Volume:33 Page:308-315
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Ahn Shin Hye¹,Boros Eszter¹

Affiliation:

1. Department of Chemistry, Stony Brook University, Stony Brook, New York.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2018.2499

Reference34 articles.

1. Current use and future potential of organometallic radiopharmaceuticals

2. Implications of PET based molecular imaging on the current and future practice of medicine

3. FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future

4. 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response

5. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Interventional Fluorescence Imaging: Toward the Precise Visualization of Transarterial Mini-Invasive Delivery Systems;Accounts of Materials Research;2023-02-16

2. Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications;Cancers;2022-03-23

3. Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge—Cell Binding Correlation;Pharmaceuticals;2021-09-28

4. 18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging;Nuclear Medicine and Biology;2021-02

5. Development of BODIPYS and aza-BODIPYs for molecular imaging applications: From the in vitro to the in vivo;Recent Highlights I;2021